Cargando…

Cancer immunotherapies: advances and bottlenecks

Immunotherapy has ushered in a new era in cancer treatment, and cancer immunotherapy continues to be rejuvenated. The clinical goal of cancer immunotherapy is to prime host immune system to provide passive or active immunity against malignant tumors. Tumor infiltrating leukocytes (TILs) play an immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Rui, Rui, Zhou, Liqun, He, Shiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484345/
https://www.ncbi.nlm.nih.gov/pubmed/37691932
http://dx.doi.org/10.3389/fimmu.2023.1212476

Ejemplares similares